| P2093 | author name string | Minoru Satoh | |
| | Gabriela Medina | |
| | Olga Vera-Lastra | |
| | Luis J. Jara | |
| | Miguel A. Saavedra | |
| | Mónica Vázquez Mercado | |
| | Pilar Cruz Dominguez | |
| P2860 | cites work | The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. | Q50852734 |
| | Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. | Q51120650 |
| | Influenza vaccine, Guillain–Barré syndrome, and chasing zero | Q57540054 |
| | Genetics of Influenza Viruses | Q22255637 |
| | Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico | Q28729170 |
| | Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis | Q30227428 |
| | Treating influenza with statins and other immunomodulatory agents. | Q30351911 |
| | Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis. | Q30352782 |
| | No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. | Q30352889 |
| | Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. | Q30373486 |
| | Pandemic (H1N1) 2009 influenza. | Q30384133 |
| | Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. | Q30385421 |
| | Clinical characteristics of fatalities due to influenza A (H1N1) virus in Mexico | Q30389992 |
| | The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation | Q30396915 |
| | Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza | Q30400817 |
| | Pandemic 2009 H1N1 virus infection associated with purpuric skin lesions: a case report | Q30401370 |
| | Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis | Q30404745 |
| | Inflammatory profiles in severe pneumonia associated with the pandemic influenza A/H1N1 virus isolated in Mexico City. | Q30405914 |
| | Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China | Q30406375 |
| | Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden | Q30408080 |
| | Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? | Q30412466 |
| | Lambert-Eaton myasthenic syndrome following H1N1-influenza vaccination: a case report | Q30416565 |
| | Defects in CD54 and CD86 up-regulation by plasmacytoid dendritic cells during pregnancy | Q30416876 |
| | Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. | Q30417745 |
| | Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis | Q30428338 |
| | Altered response to A(H1N1)pnd09 vaccination in pregnant women: a single blinded randomized controlled trial | Q30430043 |
| | High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. | Q30432642 |
| | Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines | Q33366499 |
| | A case of immune thrombocytopenic purpura after influenza vaccination: consequence or coincidence? | Q33390066 |
| | Vaccinations in patients with immune-mediated inflammatory diseases | Q34117134 |
| | Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis | Q34260259 |
| | Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. | Q34326653 |
| | Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum | Q34337165 |
| | Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome | Q34784351 |
| | Post-vaccination encephalomyelitis: literature review and illustrative case | Q34870245 |
| | Vaccination and autoimmune disease: what is the evidence? | Q35590061 |
| | Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus | Q35711767 |
| | T-cell biology in aging, with a focus on lung disease | Q35815756 |
| | Defective B cell tolerance checkpoints in systemic lupus erythematosus | Q36402748 |
| | Vaccines and autoimmunity | Q37623438 |
| | Could autoimmunity be induced by vaccination? | Q37762550 |
| | EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases | Q37816066 |
| | Progress in understanding adjuvant immunotoxicity mechanisms | Q37851636 |
| | Immunizations and risk of multiple sclerosis: systematic review and meta-analysis | Q37856884 |
| | Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature | Q37974890 |
| | Infections and vaccines in the etiology of antiphospholipid syndrome | Q38012320 |
| | When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). | Q38013584 |
| | Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination | Q38128633 |
| | Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity | Q38138659 |
| | Influenza vaccination in autoimmune rheumatic disease patients. | Q39250809 |
| | Adverse events following immunization with vaccines containing adjuvants | Q40251518 |
| | Case of microscopic polyangiitis and giant cell arteritis after influenza vaccination | Q40319880 |
| | Onset of adult-onset Still's disease following influenza vaccination | Q40333709 |
| | Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico | Q40385742 |
| | Microscopic polyangiitis after influenza vaccination | Q40498879 |
| | Severe vasculitic neuropathy following influenza vaccination | Q43068964 |
| | Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination | Q43605309 |
| P921 | main subject | influenza vaccine | Q383260 |
| P304 | page(s) | 175-184 | |
| P577 | publication date | 2015-05-15 | |
| P1476 | title | Influenza Vaccine and Autoimmune Diseases | |